Gofen & Glossberg’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $45.5M | Sell |
410,024
-3,609
| -0.9% | -$369K | 1.17% | 20 |
|
|
2022
Q3 | $35.6M | Sell |
413,633
-1,511
| -0.4% | -$135K | 1.01% | 25 |
|
|
2022
Q2 | $37.8M | Sell |
415,144
-21,491
| -5% | -$1.91M | 1% | 25 |
|
|
2022
Q1 | $35.8M | Buy |
436,635
+11,849
| +3% | +$934K | 0.82% | 32 |
|
|
2021
Q4 | $32.6M | Buy |
424,786
+2,842
| +0.7% | +$226K | 0.7% | 36 |
|
|
2021
Q3 | $31.7M | Sell |
421,944
-2,362
| -0.6% | -$180K | 0.74% | 35 |
|
|
2021
Q2 | $33M | Sell |
424,306
-15,479
| -4% | -$1.15M | 0.78% | 33 |
|
|
2021
Q1 | $32.4M | Buy |
439,785
+4,845
| +1% | +$357K | 0.83% | 31 |
|
|
2020
Q4 | $33.9M | Buy |
434,940
+9,716
| +2% | +$743K | 0.93% | 29 |
|
|
2020
Q3 | $33.7M | Buy |
425,224
+1,747
| +0.4% | +$137K | 1.04% | 29 |
|
|
2020
Q2 | $31.2M | Buy |
423,477
+6,871
| +2% | +$517K | 1.05% | 28 |
|
|
2020
Q1 | $30.6M | Buy |
416,606
+7,244
| +2% | +$569K | 1.2% | 23 |
|
|
2019
Q4 | $35.5M | Buy |
409,362
+3,678
| +0.9% | +$302K | 1.13% | 24 |
|
|
2019
Q3 | $32.6M | Buy |
405,684
+18,588
| +5% | +$1.49M | 1.1% | 28 |
|
|
2019
Q2 | $31M | Buy |
387,096
+1,502
| +0.4% | +$115K | 1.06% | 29 |
|
|
2019
Q1 | $30.6M | Sell |
385,594
-4,304
| -1% | -$322K | 1.08% | 27 |
|
|
2018
Q4 | $28.4M | Sell |
389,898
-1,732
| -0.4% | -$122K | 1.12% | 25 |
|
|
2018
Q3 | $26.5M | Sell |
391,630
-2,868
| -0.7% | -$183K | 0.91% | 34 |
|
|
2018
Q2 | $22.8M | Buy |
394,498
+3,871
| +1% | +$218K | 0.85% | 37 |
|
|
2018
Q1 | $20.3M | Sell |
390,627
-13,238
| -3% | -$715K | 0.76% | 39 |
|
|
2017
Q4 | $21.7M | Buy |
403,865
+11,558
| +3% | +$641K | 0.77% | 37 |
|
|
2017
Q3 | $24M | Buy |
392,307
+640
| +0.2% | +$38.8K | 0.89% | 30 |
|
|
2017
Q2 | $24M | Buy |
391,667
+5,438
| +1% | +$331K | 0.91% | 28 |
|
|
2017
Q1 | $23.4M | Buy |
386,229
+8,061
| +2% | +$489K | 0.92% | 28 |
|
|
2016
Q4 | $21.2M | Buy |
378,168
+2,956
| +0.8% | +$173K | 0.87% | 31 |
|
|
2016
Q3 | $22.3M | Sell |
375,212
-1,185
| -0.3% | -$69.3K | 0.93% | 32 |
|
|
2016
Q2 | $20.7M | Buy |
376,397
+1,440
| +0.4% | +$76.6K | 0.87% | 33 |
|
|
2016
Q1 | $18.9M | Buy |
374,957
+14,221
| +4% | +$696K | 0.81% | 34 |
|
|
2015
Q4 | $18.2M | Sell |
360,736
-3,744
| -1% | -$189K | 0.79% | 38 |
|
|
2015
Q3 | $17.2M | Buy |
364,480
+15,666
| +4% | +$832K | 0.78% | 37 |
|
|
2015
Q2 | $18.9M | Buy |
348,814
+16,927
| +5% | +$949K | 0.8% | 35 |
|
|
2015
Q1 | $18.2M | Buy |
331,887
+7,663
| +2% | +$434K | 0.78% | 36 |
|
|
2014
Q4 | $17.6M | Buy |
324,224
+3,885
| +1% | +$216K | 0.75% | 41 |
|
|
2014
Q3 | $18.1M | Buy |
320,339
+8,845
| +3% | +$497K | 0.8% | 38 |
|
|
2014
Q2 | $17.2M | Buy |
311,494
+2,753
| +0.9% | +$150K | 0.76% | 40 |
|
|
2014
Q1 | $16.8M | Buy |
308,741
+13,760
| +5% | +$713K | 0.78% | 39 |
|
|
2013
Q4 | $14.1M | Buy |
294,981
+4,591
| +2% | +$210K | 0.66% | 47 |
|
|
2013
Q3 | $13.2M | Buy |
290,390
+2,046
| +0.7% | +$93.4K | 0.68% | 45 |
|
|
2013
Q2 | $12.8M | Buy |
+288,344
| New | +$12.9M | 0.69% | 45 |
|
Other funds holding MRK
AWA
Gofen & Glossberg's MRK Position: Q4 2022 in Review
Gofen & Glossberg reduced its Merck (MRK) stake by 0.87% in Q4 2022, selling an estimated $369K and leaving 410,024 shares worth $45.5M. The position accounts for 1.17% of the portfolio, ranked #20.
Gofen & Glossberg first reported a position in MRK in Q2 2013 and has held it in 39 quarters since. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.
- Gofen & Glossberg held 410,024 shares of Merck worth $45.5M as of Q4 2022.
- Gofen & Glossberg sold 3,609 Merck shares in Q4 2022, an estimated $369K.
- Merck made up 1.17% of Gofen & Glossberg's portfolio in Q4 2022, its #20 holding.
- Gofen & Glossberg first reported a position in Merck in Q2 2013 and has held it in 39 quarters since.
- 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.